Laporan Laba Rugi 507789 - TTM - Jagsonpal Pharmaceuticals Limited

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Jagsonpal Pharmaceuticals Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	1,595	1,746	1,879	2,163	2,194	2,168	2,176	2,326	2,348	2,410	2,367	2,363	2,336	2,207	2,087	2,100	2,269	2,536	2,687	2,829
Change (%)		9.46	7.63	15.08	1.45	-1.20	0.36	6.92	0.92	2.65	-1.78	-0.19	-1.14	-5.53	-5.42	0.62	8.03	11.81	5.94	5.27
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	627	740	812	948	909	873	897	1,007	1,003	1,020	927	892	892	858	805	802	865	930	964	1,011
Change (%)		18.04	9.85	16.70	-4.14	-3.91	2.71	12.26	-0.35	1.66	-9.12	-3.77	-0.01	-3.80	-6.13	-0.45	7.84	7.49	3.75	4.79
% of Revenue	39.27	42.35	43.22	43.83	41.41	40.28	41.22	43.28	42.74	42.33	39.16	37.75	38.19	38.89	38.59	38.19	38.12	36.65	35.89	35.72

Gross Operating Profit	969	1,007	1,067	1,215	1,286	1,295	1,279	1,320	1,344	1,390	1,440	1,471	1,444	1,349	1,282	1,298	1,404	1,607	1,723	1,818
Change (%)		3.91	5.99	13.85	5.81	0.72	-1.22	3.18	1.88	3.39	3.61	2.12	-1.83	-6.59	-4.97	1.29	8.15	14.47	7.21	5.54
% of Revenue	60.73	57.65	56.78	56.17	58.59	59.72	58.78	56.72	57.26	57.67	60.84	62.25	61.81	61.11	61.41	61.81	61.88	63.35	64.11	64.28

SG&A	543	550	659	565	691	689	704	582	736	767	820	682	867	828	773	611	795	833	709	731
Change (%)		1.32	19.73	-14.15	22.15	-0.29	2.23	-17.39	26.59	4.14	6.94	-16.83	27.07	-4.48	-6.56	-21.05	30.22	4.77	-14.85	3.00
% of Revenue	34.04	31.51	35.05	26.14	31.48	31.77	32.36	25.00	31.36	31.82	34.64	28.87	37.10	37.51	37.06	29.08	35.05	32.84	26.40	25.83

R&D
Change (%)
% of Revenue

OpEx	1,494	1,606	1,692	1,917	1,885	1,869	1,936	2,111	2,082	2,116	2,028	2,021	2,032	1,956	1,870	1,877	1,982	2,146	2,258	2,373
Change (%)		7.49	5.34	13.31	-1.64	-0.88	3.60	9.06	-1.41	1.66	-4.15	-0.38	0.57	-3.73	-4.40	0.34	5.63	8.25	5.22	5.08
% of Revenue	93.64	91.96	90.00	88.62	85.92	86.19	88.98	90.76	88.67	87.81	85.69	85.52	87.00	88.66	89.62	89.37	87.38	84.60	84.02	83.87

Operating Income	101	140	188	246	309	299	240	215	266	294	339	342	304	250	217	223	286	391	429	456
Change (%)		38.49	33.75	31.01	25.55	-3.13	-19.86	-10.36	23.76	10.45	15.30	0.95	-11.26	-17.56	-13.42	3.04	28.20	36.46	9.93	6.27
% of Revenue	6.36	8.04	10.00	11.38	14.08	13.81	11.02	9.24	11.33	12.19	14.31	14.48	13.00	11.34	10.38	10.63	12.62	15.40	15.98	16.13

Interest Expense	-4	-4	-4	-5	-3	-3	-3	-2	-1	-3	-3	-5	-6	-7	-8	-9	-8	-9	-10	-10
Change (%)		9.42	7.01	14.15	-28.59	-22.24	-3.69	-25.86	-31.94	90.36	10.89	97.37	10.99	8.05	18.09	13.13	-3.30	3.41	8.99	4.07
% of Revenue	-0.23	-0.23	-0.23	-0.23	-0.16	-0.13	-0.12	-0.08	-0.06	-0.10	-0.12	-0.23	-0.26	-0.30	-0.37	-0.42	-0.37	-0.35	-0.36	-0.35

Net Income	104	135	171	214	247	247	189	131	198	223	267	313	283	245	225	203	243	523	554	608
Change (%)		30.36	26.23	25.37	15.42	-0.10	-23.54	-30.48	50.87	12.61	19.98	17.06	-9.40	-13.48	-8.38	-9.57	19.63	115.34	5.80	9.87
% of Revenue	6.50	7.74	9.08	9.89	11.25	11.38	8.67	5.63	8.42	9.24	11.29	13.24	12.13	11.11	10.76	9.67	10.71	20.63	20.60	21.50

Source: Capital IQ

Jagsonpal Pharmaceuticals Limited - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)

Other Listings